Introduction: We sought to examine the role of advanced age (defined as >70 years), impaired cognitive function, and decreased manual dexterity in the rates of re-operation (revision or replacement) of artificial urinary sphincters (AUS). Methods: From 1988 to 2012, 213 men underwent virgin AUS placements. Failure was defined as a revision performed for stress incontinence and replacement/exploration performed for urethral erosion/infection or mechanical failure. Kaplan-Meier curves were constructed to compare failure rates with age and Cox proportional hazard models were used to test associations. Results: Advanced age was not associated with overall failure (p = 0.48), erosion/infection failure (p = 0.65), recurrent/persistent incontinence failure (p = 0.08), or mechanical failure (p = 0.36). Controlling for age, patients with cognitive dysfunction or decreased manual dexterity showed a higher rate of overall failure (p = 0.01). Conclusions: AUS placement is an excellent option to treat stress urinary incontinence in elderly men with intact cognition and good manual dexterity. AUS placement should be performed with caution in patients with impaired cognitive function or decreased manual dexterity, and additional effort should be made to identify these conditions both before and after surgery.

Keywords:
Artificial urinary sphincter, Urinary incontinence, Complications, Elderly
1.
Wehrberger C, Madersbacher S, Jungwirth S, Fischer P, Tragl KH: Lower urinary tract symptoms and urinary incontinence in a geriatric cohort - a population-based analysis. BJU Int 2012;110:1516-1521.
2.
Collerton J, Davies K, Jagger C, Kingston A, Bond J, Eccles MP, Robinson LA, Martin-Ruiz C, von Zglinicki T, James OF, Kirkwood TB: Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009;339:b4904.
3.
Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the epic study. Eur Urol 2006;50:1306-1314; discussion 1314-1315.
4.
Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P: Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011;108:1132-1138.
5.
Kok AL, Voorhorst FJ, Burger CW, van Houten P, Kenemans P, Janssens J: Urinary and faecal incontinence in community-residing elderly women. Age Ageing 1992;21:211-215.
6.
Campbell AJ, Reinken J, McCosh L: Incontinence in the elderly: prevalence and prognosis. Age Ageing 1985;14:65-70.
7.
Ranson RN, Saffrey MJ: Neurogenic mechanisms in bladder and bowel ageing. Biogerontology 2015;16:265-284.
8.
Talasz H, Jansen SC, Kofler M, Lechleitner M: High prevalence of pelvic floor muscle dysfunction in hospitalized elderly women with urinary incontinence. Int Urogynecol J 2012;23:1231-1237.
9.
Brant WO, Erickson BA, Elliott SP, Powell C, Alsikafi N, McClung C, Myers JB, Voelzke BB, Smith TG 3rd, Broghammer JA: Risk factors for erosion of artificial urinary sphincters: a multicenter prospective study. Urology 2014;84:934-938.
10.
Venn SN, Greenwell TJ, Mundy AR: The long-term outcome of artificial urinary sphincters. J Urol 2000;164(3 pt 1):702-706; discussion 706-707.
11.
Leibovich BC, Barrett DM: Use of the artificial urinary sphincter in men and women. World J Urol 1997;15:316-319.
12.
Saga S, Vinsnes AG, Mørkved S, Norton C, Seim A: What characteristics predispose to continence in nursing home residents?: a population-based cross-sectional study. Neurourol Urodyn 2015;34:362-367.
13.
Sandhu JS: Management of complications and residual symptoms in men with an artificial urinary sphincter. J Urol 2014;192:303-304.
14.
Haab F, Trockman BA, Zimmern PE, Leach GE: Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of followup. J Urol 1997;158:435-439.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.